The preclinical study has shown that breast tumor-derived extracellular vesicles (EVs) injected into mice treated with granulocyte colony-stimulating factor accelerated venous thrombosis, suggesting that cancer-associated thrombosis may be facilitated by both neutrophils and tumor-derived EVs [9]. This evidence concerns the gene CSF3 and cancer.